EPISODE · Mar 3, 2014 · 10 MIN
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
from Journal of Clinical Oncology (JCO) Podcast
This JCO podcast provides observations and commentary on the JCO article, Survival, Durable Tumor Remission, and Long-Term Safety in Patients with Advanced Melanoma Receiving Nivolumab," by Suzanne Topalian, et al.
NOW PLAYING
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m